
The foundational pieces of multimodal treatment of canine osteoarthritis should include: nonsteroidal anti-inflammatory drugs (NSAIDs), a pet food rich in eicosapentaenoic acid (EPA), and chondroprotective injectable polysulfated glycosaminoglycan (PSGAG). The ultimate goal of a multimodal approach is to provide the maximum quality of extended life with a minimal effective dose of pharmacologics. The optimal multimodal approach is an overlapping of medical and nonmedical management.







